A Ten-Year Patterns of Use Analysis for the World’s First Commercial Compact Pencil Beam Scanning Proton Therapy System

Trends demonstrate stable patterns of use over time, despite the occurrence of global events such as the COVID-19 pandemic. Modern hypofractionation has driven steady decreases in fractionation, reducing travel burden and potential financial toxicity. Continued growth in the body of clinical evidence, paired with legislation and health policy supporting particle therapy, will allow further expansion and critical evaluation of PBT indications. Results demonstrate the feasibility and longevity of PBT in a community hospital setting.